Page 813 - medicina-integrativa_compress
P. 813

830     PARTE II,  SECCIÓN 13 CÁNCER


                   • La betacriptoxantina podría tener un             Un cuarto de taza de concentrado de
                     efecto protector.                                zumo de mandarina congelado
                                                       C   1
                                                                      (descongelado)
                   • Considerar la recomendación de una pasta
                                                                      Dos cucharaditas de jarabe de arce
                     sin grumos rica en criptoxantina
                     constituida por:                                 Media cucharadita de extracto de vainilla
                   Un mango, pelado y en dados (también
                   pueden emplearse melocotones, naranjas o         ■ Fitoterapia
                   sandía)
                                                                      • Es posible que el Panax ginseng
                   Unataza y media de yogur natural (la beta-           (100-200 mg/día) disminuya la     B B  2 2
                   criptoxantina es una vitamina liposoluble y se       incidencia de cáncer de pulmón en los
                   absorbe mejor si se toma con grasa)                  fumadores.




           BIBLIOGRAFÍA                                        18.  Ernst E: Kombucha: A systematic review of the clinical evidence.
                                                                   Forsch Komplementarmed Klass Naturheilkd 10:85-87, 2003.
            1.  Jemal A, Clegg LX, Ward E, et al: Annual report to the nation on the  19.  US Food and Drug Administration: FDA Talk Paper: FDA cautions
               status of cancer, 1975-2001, with a special feature regarding survival.  consumers on “Kombucha mushroom tea.” Rockville, Md., National
               Cancer 101:3-27, 2004.                              Press Office, March 23, 1995. Talk Paper T95-15.
            2.  Henschke CI, Shaham D, Yankelevitz DF, Altorki NK: CT Screening  20.  Knekt P, Jarvinen R, Seppanen R, et al: Dietary antioxidants and the
               for lung cancer: Past and ongoing studies. Semin Thorac Cardiovasc  risk of lung cancer. Am J Epidemiol 134:471-479, 1991.
               Surg 17:99-106, 2005.                           21.  Koo LC: Diet and lung cancer 20+ years later: More questions than
            3.  Mulshine JL, Sullivan DC: Clinical practice: Lung cancer screening.  answers? Int J Cancer 1997;(Suppl 10):22-29.
               N Engl J Med 352:2714-2720, 2005.               22.  Yu SY, Mao BL, Xiao P, et al: Intervention trial with selenium for
            4.  US Preventive Services Task Force: Guide to Clinical Prevention  the prevention of lung cancer among tin miners in Yunnan, China:
               Services, 2nd ed. Washington, DC, US•Department of Health and  A pilot study. Biol Trace Elem Res 24:105-108, 1990.
               Human Services Office of Disease Prevention and Health  23.  Blot WJ, Li JY, Taylor PR, et al: Nutrition intervention trials in
               Promotion, 1996.                                    Linxian, China: Supplementation with specific vitamin/mineral
            5.  Haussinger K, Becker H, Stanzel F, et al: Autofluorescence  combinations, cancer incidence, and disease-specific mortality in the
               bronchoscopy with white light bronchoscopy compared with white  general population. J Natl Cancer Inst 85:1483-1492, 1993.
               light bronchoscopy alone for the detection of precancerous lesions:  24.  Clark LC, Combs GF Jr, Turnbull BW, et al: Effects of selenium
               A European randomised controlled multicentre trial. Thorax 60:  supplementation for cancer prevention in patients with carcinoma
               496-503, 2005.                                      of the skin: A randomized controlled trial. Nutritional Prevention of
            6.  Dorant E, van den Brandt PA, Goldbohm RA: A prospective cohort  Cancer Study Group. JAMA 276:1957-1963, 1996.
               study on Allium vegetable consumption, garlic supplement use, and  25.  Zhuo H, Smith AH, Steinmaus C: Selenium and lung cancer:
               the risk of lung carcinoma in The Netherlands. Cancer Res 54:  A quantitative analysis of heterogeneity in the current epidemiological
               6148-6153, 1994.                                    literature. Cancer Epidemiol Biomarkers Prev 13:771-778, 2004.
            7.  Goldbohm RA, Hertog MG, Brants HA, et al: Consumption of black  26.  Omenn GS: Chemoprevention of lung cancer: The rise and demise
               tea and cancer risk: A prospective cohort study. J Natl Cancer Inst  of beta-carotene. Annu Rev Public Health 19:73-99, 1998.
               88:93-100, 1996.                                27.  Pryor WA, Stahl W, Rock CL: Beta carotene: From biochemistry to
            8.  Leanderson P, Faresjo AO, Tagesson C: Green tea polyphenols  clinical trials. Nutr Rev 58:39-53, 2000.
               inhibit oxidant-induced DNA strand breakage in cultured lung cells.  28.  Ziegler RG, Mason TJ, Stemhagen A, et al: Carotenoid intake,
               Free Radic Biol Med 23:235-242, 1997.               vegetables, and the risk of lung cancer among white men in New
            9.  Hu G, Han C, Chen J: Inhibition of oncogene expression by green tea  Jersey. Am J Epidemiol 123:1080-1093, 1986.
               and (-)-epigallocatechin gallate in mice. Nutr Cancer 24:203-209, 1995.  29.  Bandera EV, Freudenheim JL, Marshall JR, et al: Diet and alcohol
           10.  Luo SQ, Liu XZ, Wang CJ: Inhibitory effect of green tea extract on  consumption and lung cancer risk in the New York State Cohort
               the carcinogenesis induced by asbestos plus benzo(a)pyrene in rat.  (United States). Cancer Causes Control 8:828-840, 1997.
               Biomed Environ Sci 8:54-58, 1995.               30.  Yong LC, Brown CC, Schatzkin A, et al: Intake of vitamins E, C, and
           11.  Chung FL, Schwartz J, Herzog CR, Yang YM: Tea and cancer  A and risk of lung cancer. The NHANES I epidemiologic followup
               prevention: Studies in animals and humans. J Nutr 133:3268S-  study. First National Health and Nutrition Examination Survey. Am
               3274S, 2003.                                        J Epidemiol 146:231-243, 1997.
           12.  Lee YS, Chung IS, Lee IR, Kim KH, et al: Activation of multiple  31.  Ocke MC, Bueno-de-Mesquita HB, Feskens EJ, et al: Repeated
               effector pathways of immune system by the antineoplastic  measurements of vegetables, fruits, beta-carotene, and vitamins C
               immunostimulator acidic polysaccharide ginsan isolated from Panax  and E in relation to lung cancer. The Zutphen Study. Am J
               ginseng. Anticancer Res 17:323-331, 1997.           Epidemiol 145:358-365, 1997.
           13.  Cheng CC, Yang SM, Huang CY, et al: Molecular mechanisms of  32.  Mannisto S, Smith-Warner SA, Spiegelman D, et al: Dietary
               ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human  carotenoids and risk of lung cancer in a pooled analysis of seven
               lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol  cohort studies. The Beta-Carotene and Retinol Efficacy Trial:
               55:531-540, 2005.                                   Incidence of lung cancer and cardiovascular disease mortality during
           14.  Shin HR, Kim JY, Yun TK, et al: The cancer-preventive potential of  6-year follow-up after stopping beta-carotene and retinol
               Panax ginseng: A review of human and experimental evidence.  supplements. Cancer Epidemiol Biomarkers Prev 13:40-48, 2004.
               Cancer Causes Control 11:565-576, 2000.         33.  Comstock GW, Alberg AJ, Huang HY, et al: The risk of developing
           15.  Yun TK, Choi SY, Yun HY: Epidemiological study on cancer  lung cancer associated with antioxidants in the blood: Ascorbic acid,
               prevention by ginseng: Are all kinds of cancers preventable by  carotenoids, alpha-tocopherol, selenium, and total peroxyl radical
               ginseng? J Korean Med Sci 16(Suppl):S19-27, 2001.   absorbing capacity. Cancer Epidemiol Biomarkers Prev 6:907-916,
           16.  Nanba H, Kubo K: Effect of Maitake D-fraction on cancer  1997.
               prevention. Ann N Y Acad Sci 833:204-207, 1997.  34.  Stahelin HB, Gey KF, Eichholzer M, et al: Plasma antioxidant
           17.  Kodama N, Komuta K, Nanba H: Can maitake MD-fraction aid  vitamins and subsequent cancer mortality in the 12-year follow-up
               cancer patients? Altern Med Rev 7:236-239, 2002.    of the prospective Basel Study. Am J Epidemiol 133:766-775, 1991.
   808   809   810   811   812   813   814   815   816   817   818